Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves' disease

Endocrine. 2019 Jan;63(1):164-166. doi: 10.1007/s12020-018-1735-9. Epub 2018 Sep 3.

Authors

Mahmoud Al Majdoub¹, Mikael Lantz^{1

2}, Peter Spégel^{3

4}

Affiliations

¹ Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
² Department of Endocrinology, Skåne University Hospital, Malmö, Sweden.
³ Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden. peter.spegel@chem.lu.se.
⁴ Department of Chemistry, Centre for Analysis and Synthesis, Lund University, Lund, Sweden. peter.spegel@chem.lu.se.

PMID: 30178436
DOI: 10.1007/s12020-018-1735-9

No abstract available

Publication types

Letter

MeSH terms

Adult
Antithyroid Agents / therapeutic use
Carnitine / analogs & derivatives*
Carnitine / blood
Female
Graves Disease / blood*
Graves Disease / surgery
Graves Disease / therapy*
Humans
Iodine Radioisotopes / therapeutic use
Male
Middle Aged
Predictive Value of Tests
Weight Gain*

Substances

Antithyroid Agents
Iodine Radioisotopes
acylcarnitine
Carnitine